ERK1/2 Signaling Plays an Important Role in Topoisomerase II Poison-Induced G2/M Checkpoint Activation

Topo II poisons, which target topoisomerase II (topo II) to generate enzyme mediated DNA damage, have been commonly used for anti-cancer treatment. While clinical evidence demonstrate a capability of topo II poisons in inducing apoptosis in cancer cells, accumulating evidence also show that topo II poison treatment frequently results in cell cycle arrest in cancer cells, which was associated with subsequent resistance to these treatments. Results in this report indicate that treatment of MCF-7 and T47D breast cancer cells with topo II poisons resulted in an increased phosphorylation of extracellular signal-regulated kinase 1 and 2 (ERK1/2) and an subsequent induction of G2/M cell cycle arrest. Furthermore, inhibition of ERK1/2 activation using specific inhibitors markedly attenuated the topo II poison-induced G2/M arrest and diminished the topo II poison-induced activation of ATR and Chk1 kinases. Moreover, decreased expression of ATR by specific shRNA diminished topo II poison-induced G2/M arrest but had no effect on topo II poison-induced ERK1/2 activation. In contrast, inhibition of ERK1/2 signaling had little, if any, effect on topo II poison-induced ATM activation. In addition, ATM inhibition by either incubation of cells with ATM specific inhibitor or transfection of cells with ATM specific siRNA did not block topo II poison-induced G2/M arrest. Ultimately, inhibition of ERK1/2 signaling greatly enhanced topo II poison-induced apoptosis. These results implicate a critical role for ERK1/2 signaling in the activation of G2/M checkpoint response following topo II poison treatment, which protects cells from topo II poison-induced apoptosis.

• Publication year

  2012

• Venue

  PLoS ONE

• Publication date

  2012-11-16

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1371/journal.pone.0050281PMID 23166842PMCID 3500378
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fas/FasL-dependent and -independent activation of caspase-8 in doxorubicin-treated human breast cancer MCF-7 cells: ADAM10 down-regulation activates Fas/FasL signaling pathway.

  2011cited by this paper
• Simultaneous exposure of transformed cells to SRC family inhibitors and CHK1 inhibitors causes cell death

  2011cited by this paper
• Both ERK1 and ERK2 kinases promote G2/M arrest in etoposide-treated MCF7 cells by facilitating ATM activation.

  2010cited by this paper
• HERC2 is an E3 ligase that targets BRCA1 for degradation.

  2010cited by this paper
• Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2.

  2009cited by this paper
• Targeting DNA topoisomerase II in cancer chemotherapy

  2009cited by this paper
• Doxorubicin Exerts Cytotoxic Effects through Cell Cycle Arrest and Fas-Mediated Cell Death

  2009cited by this paper
• Gamma-irradiation-induced DNA damage checkpoint activation involves feedback regulation between extracellular signal-regulated kinase 1/2 and BRCA1.

  2008cited by this paper
• Mechanisms underlying the pro-survival pathway of p53 in suppressing mitotic death induced by adriamycin.

  2008cited by this paper
• G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer

  2008cited by this paper
• Irradiation-induced G2/M checkpoint response requires ERK1/2 activation

  2007cited by this paper
• Cellular response to etoposide treatment.

  2007cited by this paper
• p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage.

  2007influential reference
• Interplay between PI3K/Akt and MAPK signaling pathways in DNA-damaging drug-induced apoptosis.

  2006cited by this paper
• Superoxide Anions Are Involved in Doxorubicin‐Induced ERK Activation in Hepatocyte Cultures

  2006cited by this paper
• Activation of Akt and ERK signalling pathways induced by etoposide confer chemoresistance in gastric cancer cells.

  2006cited by this paper
• p53 and breast cancer, an update.

  2006cited by this paper
• G2 damage checkpoints: what is the turn-on?

  2005cited by this paper
• Etoposide, topoisomerase II and cancer.

  2005cited by this paper
• Hematopoietic cytokines enhance Chk1-dependent G2/M checkpoint activation by etoposide through the Akt/GSK3 pathway to inhibit apoptosis

  2005cited by this paper
• Cdk5 Activator-binding Protein C53 Regulates Apoptosis Induced by Genotoxic Stress via Modulating the G2/M DNA Damage Checkpoint*

  2005cited by this paper
• The relative contribution of CHK1 and CHK2 to Adriamycin-induced checkpoint.

  2005cited by this paper
• BRCA1-mediated G2/M cell cycle arrest requires ERK1/2 kinase activation

  2005cited by this paper
• The cell cycle phases of DNA damage and repair initiated by topoisomerase II-targeting chemotherapeutic drugs.

  2005cited by this paper
• p21-Mediated nuclear retention of cyclin B1-Cdk1 in response to genotoxic stress.

  2004cited by this paper
• Analyzing cell cycle checkpoints after ionizing radiation.

  2004cited by this paper
• Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes

  2004cited by this paper
• Dual phosphorylation controls Cdc25 phosphatases and mitotic entry

  2003cited by this paper
• Chk1 Kinase Negatively Regulates Mitotic Function of Cdc25A Phosphatase through 14-3-3 Binding

  2003cited by this paper
• DNA damage checkpoint control in cells exposed to ionizing radiation

  2003cited by this paper
• MAPK pathways in radiation responses

  2003cited by this paper
• Phosphorylation of serine 10 in histone H3, what for?

  2003cited by this paper
• The JNK, ERK and p53 pathways play distinct roles in apoptosis mediated by the antitumor agents vinblastine, doxorubicin, and etoposide.

  2003cited by this paper
• ERK Activation Mediates Cell Cycle Arrest and Apoptosis after DNA Damage Independently of p53*

  2002cited by this paper
• BRCA1-induced Apoptosis Involves Inactivation of ERK1/2 Activities*

  2002cited by this paper
• Two Molecularly Distinct G2/M Checkpoints Are Induced by Ionizing Irradiation

  2002influential reference
• UCN-01 inhibits p53 up-regulation and abrogates gamma-radiation-induced G(2)-M checkpoint independently of p53 by targeting both of the checkpoint kinases, Chk2 and Chk1.

  2002cited by this paper
• BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage

  2002cited by this paper
• Localization of human Cdc25C is regulated both by nuclear export and 14-3-3 protein binding

  2001cited by this paper
• Cell cycle checkpoint signaling through the ATM and ATR kinases.

  2001cited by this paper
• Threonine 68 of Chk2 Is Phosphorylated at Sites of DNA Strand Breaks*

  2001cited by this paper
• Checking out the G(2)/M transition.

  2001influential reference
• ATR-Mediated Checkpoint Pathways Regulate Phosphorylation and Activation of Human Chk1

  2001cited by this paper
• Involvement of Brca1 in S-Phase and G2-Phase Checkpoints after Ionizing Irradiation

  2001cited by this paper
• Doxorubicin-induced apoptosis and chemosensitivity in hepatoma cell lines

  2001cited by this paper
• Role for ATM in DNA damage-induced phosphorylation of BRCA1.

  2000cited by this paper
• p21 Inhibits Thr161 Phosphorylation of Cdc2 to Enforce the G2 DNA Damage Checkpoint*

  2000cited by this paper
• Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint.

  2000cited by this paper
• Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation.

  2000cited by this paper
• Growth arrest and cell death in the breast tumor cell in response to ionizing radiation and chemotherapeutic agents which induce DNA damage

  2000cited by this paper
• Cisplatin‐induced response of c‐jun N‐terminal kinase 1 and extracellular signal‐regulated protein kinases 1 and 2 in a series of cisplatin‐resistant ovarian carcinoma cell lines

  2000cited by this paper
• Requirement for ERK Activation in Cisplatin-induced Apoptosis*

  2000cited by this paper
• Dual topoisomerase I/II inhibitors

  2000cited by this paper
• Identification of a Novel Phosphorylation Site on Histone H3 Coupled with Mitotic Chromosome Condensation*

  1999cited by this paper
• Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine.

  1999cited by this paper
• Phosphorylation-induced Rearrangement of the Histone H3 NH2-terminal Domain during Mitotic Chromosome Condensation

  1999cited by this paper
• ATR is a caffeine-sensitive, DNA-activated protein kinase with a substrate specificity distinct from DNA-PK

  1999cited by this paper
• Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs

  1999cited by this paper
• Distinct Roles for PP1 and PP2A in Phosphorylation of the Retinoblastoma Protein

  1999cited by this paper
• Regulation of BRCA1 and BRCA2 expression in human breast cancer cells by DNA-damaging agents

  1998cited by this paper
• Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase*

  1998cited by this paper
• Activation of the ATM kinase by ionizing radiation and phosphorylation of p53.

  1998cited by this paper
• p27Kip1 overexpression causes apoptotic death of mammalian cells

  1997cited by this paper
• Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation

  1997cited by this paper
• 14-3-3sigma is a p53-regulated inhibitor of G2/M progression.

  1997cited by this paper
• Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents.

  1997cited by this paper
• Inhibition of Protein Phosphatase Activity Induces p53-dependent Apoptosis in the Absence of p53 Transactivation*

  1997cited by this paper
• Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216.

  1997cited by this paper
• Cdc2 tyrosine phosphorylation is required for the DNA damage checkpoint in fission yeast.

  1997cited by this paper
• 14-3-3σ Is a p53-Regulated Inhibitor of G2/M Progression

  1997cited by this paper
• Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway.

  1997cited by this paper
• Chk1 is a wee1 kinase in the G2 DNA damage checkpoint inhibiting cdc2 by Y15 phosphorylation

  1997cited by this paper
• Inhibition of cyclin-dependent kinases by p21.

  1995cited by this paper
• Cell cycle regulation of human WEE1.

  1995cited by this paper
• The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest

  1994influential reference
• Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE

  1994cited by this paper
• Ionizing radiation induces rapid tyrosine phosphorylation of p34cdc2.

  1994cited by this paper
• Human Wee1 kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr15.

  1993cited by this paper
• p107wee1 is a dual-specificity kinase that phosphorylates p34cdc2 on tyrosine 15.

  1992influential reference
• mik1 and wee1 cooperate in the inhibitory tyrosine phosphorylation of cdc2.

  1991influential reference
• Mutations in the p53 gene occur in diverse human tumour types

  1989cited by this paper

• Palindromic carbazole derivatives: unveiling their antiproliferative effect via topoisomerase II catalytic inhibition and apoptosis induction

  2024cites this paper
• Correction: ERK1/2 Signaling Plays an Important Role in Topoisomerase II Poison-Induced G2/M Checkpoint Activation

  2023cites this paper
• ERK2-topoisomerase II regulatory axis is important for gene activation in immediate early genes

  2023cites this paper
• Biological Activity of a Thiobarbituric Acid Compound in Neuroblastomas

  2021cites this paper
• Design, synthesis and anticancer activity of 2-arylimidazo[1,2-a]pyridinyl-3-amines.

  2021cites this paper
• Transcriptome Analysis Reveals the Anti-cancerous Mechanism of Licochalcone A on Human Hepatoma Cell HepG2

  2021cites this paper
• Inhibition of the Extracellular Signal e Regulated Kinase/Ribosomal S6 Kinase Cascade Limits Chlamydia trachomatis Infection

  2021cites this paper
• Inhibition of the ERK/RSK kinase cascade limits Chlamydia trachomatis infection.

  2020cites this paper
• Gamma Tocopherol Reduced Chemotherapeutic-Induced ROS in an Ovarian Granulosa Cell Line, But Not in Breast Cancer Cell Lines In Vitro

  2020cites this paper
• Inhibition of Cell Cycle and Induction of Apoptosis y Ethanol Leaves Extract of Chrysanthemum cinerariifolium (Trev.) In T47D Breast Cancer Cells

  2020cites this paper
• The Long-Lasting Protective Effect of HGF in Cardiomyoblasts Exposed to Doxorubicin Requires a Positive Feed-Forward Loop Mediated by Erk1,2-Timp1-Stat3

  2020cites this paper
• EGF receptor and PKCδ kinase activate DNA damage–induced pro-survival and pro-apoptotic signaling via biphasic activation of ERK and MSK1 kinases

  2019cites this paper
• Assessment of doxorubicin-induced remodeling of Ca2+ signaling and associated Ca2+ regulating proteins in MDA-MB-231 breast cancer cells.

  2019cites this paper
• Combination of Curcuma (Curcuma xanthorriza Roxb) and Awar-awar (Ficus septica Burm.F.) Ethanolic Extracts Enhance Doxorubicin to Modulate Cell Cycle Progression of T47D Cells

  2018cites this paper
• Potential targets of TMEM176A in the growth of glioblastoma cells

  2018cites this paper
• STAT3 as a promising chemoresistance biomarker associated with the CD44+/high/CD24‐/low/ALDH+ BCSCs‐like subset of the triple‐negative breast cancer (TNBC) cell line

  2018cites this paper
• Co-dependency of PKCδ and K-Ras: Inverse association with cytotoxic drug sensitivity in KRAS mutant lung cancer

  2017cites this paper
• Multifunctional roles of PKCδ: Opportunities for targeted therapy in human disease.

  2016cites this paper
• Down regulation of Chk1 by p53 plays a role in synergistic induction of apoptosis by chemotherapeutics and inhibitors for Jak2 or BCR/ABL in hematopoietic cells

  2016cites this paper
• Guiding TRAIL to cancer cells through Kv10.1 potassium channel overcomes resistance to doxorubicin

  2016cites this paper
• Ubiquitin-specific protease 39 is overexpressed in human lung cancer and promotes tumor cell proliferation in vitro

  2016cites this paper
• Benfluron Induces Cell Cycle Arrest, Apoptosis and Activation of p53 Pathway in MOLT-4 Leukemic Cells.

  2015cites this paper
• CorepressorFunction of a Transcriptional SMRT: a Histone Deacetylase Activation of p53 Transcriptional Activity by

  2014cites this paper
• Characterization of a Novel Anti-Cancer Compound for Astrocytomas

  2014cites this paper
• ERK1/2 inhibition enhances apoptosis induced by JAK2 silencing in human gastric cancer SGC7901 cells

  2014cites this paper
• Topoisomerase IIα in Chromosome Instability and Personalized Cancer Therapy

  2014cites this paper
• A novel function of HER2/Neu in the activation of G2/M checkpoint in response to γ-irradiation

  2014cites this paper
• Evaluation de combinaisons thérapeutiques ciblées en cancérologie des voies aérodigestives supérieures. Mise au point d’un modèle tumoral in vivo

  2014cites this paper
• A recently evolved class of alternative 3′-terminal exons involved in cell cycle regulation by topoisomerase inhibitors

  2014cites this paper
• The antitumor drug F14512 enhances cisplatin and ionizing radiation effects in head and neck squamous carcinoma cell lines.

  2014cites this paper
• Activation of p53 Transcriptional Activity by SMRT: a Histone Deacetylase 3-Independent Function of a Transcriptional Corepressor

  2014influential citation
• A western blot assay to measure cyclin dependent kinase activity in cells or in vitro without the use of radioisotopes

  2013cites this paper
• AVALIAÇÃO DA ATIVIDADE ANTINEOPLÁSICA DO EXTRATO ETANÓLICO DA PRÓPOLIS G6 BAIANA

  2013cites this paper
• Symmetrically substituted carbazole derivatives exert antiproliferative effects through catalytic inhibition of topoisomerase II and apoptosis induction

  year unknowncites this paper